[1] |
ZHONG Wei, SHI Shuxia, QIN Qinyue, YU Guo.
Measurement tools and rationality evaluation of clinical research coordinator's work ability and workload
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 937-947.
|
[2] |
LI Qingna, HUANG Ke, LU Fang, ZHAO Yang, QIU Panbo, WANG Shuge, GAO Rui.
Characteristic and development of standard operating procedure of electronic data management in traditional Chinese medicine clinical research
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 550-554.
|
[3] |
CHE Jinjing.
Application of biomarkers in clinical development of biologics and bioanalytical strategies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 22-31.
|
[4] |
CHANG Qingqing, PENG Ying, WANG Guangji, SUN Jianguo.
Clinical research progress of small molecule tyrosine kinase inhibitors as anti-hepatocellular carcinoma agents
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 948-956.
|
[5] |
XIAO Liang, ZHENG Gaozhe, HUANG Yumin.
Research progress on risk-based management in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 955-960.
|
[6] |
SHAN Jiao-jiao,TANG Yi-qun,SHI Mei-qi, XIA Guo-hao, WANG Li,FANG Ying,ZHAO Jie.
Impact of clinical pharmacists on protocol deviation in anti-cancer drug clinical trial
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 33-37.
|
[7] |
WANG Hui, HU Si-yuan.
Clinical research design technical points on child anorexia treated by new TCM drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(10): 1191-1195.
|
[8] |
LI Wei, BO Qing-yan, ZOU Jian-dong, XIONG Ning-ning.
Application of edit checks in clinical research data management
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 76-79.
|
[9] |
.
Key activities involved in conduct of clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(3): 357-360.
|
[10] |
BO Qing-yan, XIONG Ning-ning, ZOU Jian-dong, JIANG Meng, LIU Fang, WANG Xiu-qin, GAO Wei-min.
Key role in clinical trial:clinical research coordinator
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1190-1193.
|
[11] |
WANG Xiu-qin, XIONG Ning-ning, LIU Shen-lin, LI Qi-yi, JIANG Meng, LIU Fang, GAOWei-min.
Ethic review in clinical research:medical devices
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(12): 1437-1440.
|
[12] |
WANG Xiu-Qin, XIONG Ning-Ning, LIU Shen-Lin, GAO Wei-Min, JIANG Meng, LIU Fang, ZOU Jian-Dong, BO Qing-Yan.
Ethic review in clinical research:conflicts of interest
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 358-360.
|
[13] |
WANG Xiu-Qin, XIONG Ning-Ning, LIU Shen-Lin, LI Qi-Yi, JIANG Meng, LIU Fang, ZOU Jian-Dong, BO Qing-Yan, GAO Wei-Min.
Ethic review in clinical research:informed consent
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(1): 117-120.
|
[14] |
WANG Xiu-Qin, XIONG Ning-Ning, LIU Shen-LIn, LI Qi-Yi, JIANG Meng, LIU Fang, ZOU Jian-Dong, BO Qing-Yan, GAO Wei-Min.
Ethic review in clinical research :risk/benefit analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 718-720.
|